Breakfast replacement by a low-glycemic index liquid formula in patients with diabetes mellitus type 2.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22156

Enrollment

Registered

2011-02-21

Start date

2011-02-24

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes glycemic index glycemische index breakfast ontbijt

Interventions

Isoenergetic replacement of regular whole-food breakfast by Glucerna SR drinkvoeding (Abbott Laboratories B.V., Zwolle, Netherlands) will be compared to regular whole-food breakfast. Both will be give

Eligibility

Inclusion criteria

Inclusion criteria: 1. DM2; 2. Age 30-75y; 3. Body mass index 25-40 kg/m2.

Exclusion criteria

Exclusion criteria: 1. Use of any other anti-diabetic drug than metformin; 2. Acute or chronic metabolic disease (other than diabetes) that will impair metabolism or digestion and absorption of food, including gastrointestinal, hepatic or renal disease; 3. Regular breakfast skipping; 4. Inability to give written informed consent.

Design outcomes

Primary

Measure	Time frame
Fasting and postprandial glucose and insulin concentrations.	—

Secondary

Measure	Time frame
1. Body weight; 2. HbA1c; 3. Glucose tolerance (determined by an oral glucose tolerance test); 4. Plasma lipid concentrations; 5. Oxidative stress.	—

Contacts

Public ContactP.H.L.T. Bisschop

Meibergdreef 9, Room F5-165

p.h.bisschop@amc.uva.nl+31 (0)20 5666071

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)